Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd

$DCALPharmaceuticalsNSEBSE

Dishman Carbogen Amcis Ltd (DCAL) last traded at ₹172, a market capitalisation of ₹2,694 crore, on a P/E of 149. Over the past 52 weeks the stock has ranged between ₹128 and ₹322. Dishman Carbogen Amcis Ltd last reported results for the quarter ended Jun 2026, with sales of ₹678 crore and net profit of ₹-58 crore. Figures are as of 25 Aug 2026 and are not real time.

Dishman Carbogen Amcis Ltd share price and key metrics

Current price
₹172
Market cap
₹2,694 cr
Stock P/E
149
Book value
₹426
ROE
1.58%
ROCE
3.15%
Dividend yield
0.00%
52w high / low
322/128

Metrics as of 25 Aug 2026. Not real time.

Dishman Carbogen Amcis Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹678 cr, down 4.2% from ₹708 cr a year earlier. Net profit swung to a loss of ₹58 cr.

Dishman Carbogen Amcis Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales789682716708653720851678
Expenses642542564567504607688618
Operating profit14714015314114911316360
OPM %19%21%21%20%23%16%19%9%
Other income48-422871516
Interest3749424342464337
Depreciation7272798184848991
Profit before tax4227283931-1046-51
Tax %21%83%-56%39%-114%24%53%13%
Net profit335432365-1322-58
EPS (₹)2.110.302.751.494.16-0.831.39-3.69

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Dishman Carbogen Amcis Ltd annual results

Dishman Carbogen Amcis Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,9122,1412,4132,6162,7122,9322,901
Operating profit274331332286469566485
OPM %14%15%14%11%17%19%17%
Net profit-16518-30-15339716
EPS (₹)-10.531.15-1.90-9.790.216.221.03

TTM is the trailing twelve months to the most recent quarter.

Dishman Carbogen Amcis Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
9%
3 Years
7%
TTM
0%
Compounded Profit Growth
10 Years
%
5 Years
21%
3 Years
140%
TTM
-85%
Stock Price CAGR
10 Years
%
5 Years
-1%
3 Years
4%
1 Year
-38%
Return on Equity
10 Years
1%
5 Years
0%
3 Years
0%
Last Year
2%

Dishman Carbogen Amcis Ltd shareholding pattern

Promoters held 59.32% at Jun 2026, broadly unchanged since Jun 2025. FIIs 6.86% and DIIs 2.06%.

Dishman Carbogen Amcis Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters59.32%59.32%59.32%59.32%59.32%59.32%59.32%59.32%
FIIs8.18%8.75%9.49%9.94%8.07%7.66%7.45%6.86%
DIIs1.22%1.42%1.26%1.27%1.37%1.27%1.63%2.06%
Public31.29%30.51%29.94%29.48%31.23%31.75%31.60%31.76%
No. of shareholders55,28052,82250,75749,74449,45548,48149,00949,430

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Dishman Carbogen Amcis Ltd corporate filings

  • Announcement under Regulation 30 (LODR)-Earnings Call TranscriptCompany Updatehigh impact
    Filing PDF

    Cruxal's analysis: Dishman Carbogen Amcis reported a soft Q1 FY27 with revenue of INR 677.6 crore, a 4% YoY…

    Read the full analysis
  • The audio recording of Conference call arranged by the Company with investors on Monday, 17th August, 2026 which was commenced at 17:00 hrs (IST) to discuss the financial result and performance ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Dishman Carbogen Amcis Limited has filed the audio recording of its investor conference…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-AllotmentCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Dishman Carbogen Amcis Ltd has formally intimated the allotment of Non-Convertible…

    Read the full analysis
  • Pls. find enclosed herewith Investor Presentation.Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Dishman Carbogen Amcis Limited reported a weak Q1 FY27 performance with net revenue…

    Read the full analysis
  • UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS'' LIMITED REVIEW REPORT FOR THE FIRST QUARTER ENDED 30/06/2026Resulthigh impact
    Filing PDF

    Cruxal's analysis: Dishman Carbogen Amcis Limited reported a consolidated net loss of 57.88 crore for the…

    Read the full analysis
  • The Company has arranged Conference Call with Investors on Monday, 17th August, 2026 at 17:00 hrs. (IST) to discuss the financial result and performance of the Company for the first quarter ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Dishman Carbogen Amcis Limited has issued a revised notification regarding its upcoming…

    Read the full analysis
  • The Company has arranged Conference Call with Investors on Monday, 17th August, 2026 at 17:00 hrs. (IST) to discuss the financial result and performance of the Company for the first quarter ....Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Dishman Carbogen Amcis Limited has announced an investor conference call to discuss its…

    Read the full analysis
  • We would like to inform you that the Board of Directors of the Company has at its meeting held today, i.e., Wednesday, August 12, 2026 which was commenced at 10:30 a.m. and concluded at ....Board Meetingmedium impact
    Filing PDF

    Cruxal's analysis: Dishman Carbogen Amcis Limited has received board approval to issue senior, secured…

    Read the full analysis
  • Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the un-audited financial ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Dishman Carbogen Amcis Limited has formally notified the stock exchanges that a Board of…

    Read the full analysis
  • Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Proposal Of Fund ....Board Meetingmedium impact
    Filing PDF

    Cruxal's analysis: Dishman Carbogen Amcis Limited has scheduled a Board of Directors meeting for August 12…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Dishman Carbogen Amcis Ltd

Cruxal reads every Dishman Carbogen Amcis Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.